» Authors » C Norman Coleman

C Norman Coleman

Explore the profile of C Norman Coleman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 225
Citations 6584
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Snider J, Snider J, Mayr N, Molitoris J, Chhabra A, Mossahebi S, et al.
Pract Radiat Oncol . 2024 Oct; PMID: 39447865
Purpose: Since the inaugural workshop "Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy." hosted by the National Cancer Institute and sponsored by the Radiosurgery Society (RSS), growing collaborations and...
2.
Dosanjh M, Gershan V, Wendling E, Khader J, Ige T, Ristova M, et al.
Lancet Oncol . 2024 Oct; 25(11):1487-1495. PMID: 39426390
Background: Only 10-40% of patients with cancer in low-income and middle-income countries were able to access curative or palliative radiotherapy in 2015. We aimed to assess the current status of...
3.
Aryankalayil M, Patel H, May J, Shankavaram U, Bylicky M, Martello S, et al.
Sci Rep . 2024 Oct; 14(1):22957. PMID: 39362942
Radiation injury, either from radiotherapy or a mass-casualty event requires a health care system that can efficiently allocate resources to patients. We conducted a comprehensive transcriptome analysis of whole blood...
4.
Prasanna P, Ahmed M, Hong J, Coleman C
Lancet Oncol . 2024 Oct; 25(10):e501-e511. PMID: 39362261
Drug-radiation combination therapy is a practical approach to improving clinical outcomes for many tumours. Unfortunately, most clinical combination studies combine drugs with radiotherapy empirically and do not exploit mechanistic synergy...
5.
Grover S, Court L, Amoo-Mitchual S, Longo J, Rodin D, Scott A, et al.
Semin Radiat Oncol . 2024 Sep; 34(4):477-493. PMID: 39271284
There has long existed a substantial disparity in access to radiotherapy globally. This issue has only been exacerbated as the growing disparity of cancer incidence between high-income countries (HIC) and...
6.
Martello S, Ueda Y, Bylicky M, Pinney J, Dalo J, Scott K, et al.
Radiat Res . 2024 Aug; 202(3):489-502. PMID: 39089691
Radiation exposure in a therapeutic setting or during a mass casualty event requires improved medical triaging, where the time to delivery and quantity of medical countermeasures are critical to survival....
7.
Abdel-Wahab M, Coleman C, Eriksen J, Lee P, Kraus R, Harsdorf E, et al.
Lancet Oncol . 2024 May; 25(6):e270-e280. PMID: 38821101
Although radiotherapy continues to evolve as a mainstay of the oncological armamentarium, research and innovation in radiotherapy in low-income and middle-income countries (LMICs) faces challenges. This third Series paper examines...
8.
Bylicky M, Shankavaram U, Aryankalayil M, Chopra S, Naz S, Sowers A, et al.
Mol Cancer Ther . 2024 Feb; 23(4):577-588. PMID: 38359816
Treatments involving radiation and chemotherapy alone or in combination have improved patient survival and quality of life. However, cancers frequently evade these therapies due to adaptation and tumor evolution. Given...
9.
Taliaferro L, Agarwal R, Coleman C, DiCarlo A, Hofmeyer K, Loelius S, et al.
Int J Radiat Biol . 2023 Nov; 100(3):466-485. PMID: 37991728
Purpose: The workshop addressed the role of sex as a confounder in radiation research and its implication in real-world radiological and nuclear applications. Methods: In April 2022, HHS-wide partners from...
10.
Coleman C, Wong R, Petereit D, Maguire P, Heron D, Steinberg M, et al.
J Natl Cancer Inst . 2023 Sep; 115(12):1465-1474. PMID: 37707545
The burden of cancer and access to effective treatment are not experienced equally by all in the United States. For underserved populations that often access the health-care system when their...